tiprankstipranks
Advertisement
Advertisement

ADMA Stock Latest News

Adma Biologics price target lowered to $17 from $20 at Mizuho
The FlyAdma Biologics price target lowered to $17 from $20 at Mizuho
5d ago
ADMA
ADMA Shareholder Alert: August 10, 2026 Lead Plaintiff Deadline in ADMA BIOLOGICS, INC. Securities Class Action – Contact Levi & Korsinsky
PremiumClass Action
ADMA Shareholder Alert: August 10, 2026 Lead Plaintiff Deadline in ADMA BIOLOGICS, INC. Securities Class Action – Contact Levi & Korsinsky
5d ago
ADMA
ADMA: Buy Rating Reiterated on Strong IG Product Momentum, Conservative Expectations and Unchanged $18 Price Target
PremiumRatings
ADMA: Buy Rating Reiterated on Strong IG Product Momentum, Conservative Expectations and Unchanged $18 Price Target
1M ago
ADMA
Nutrien, CAVA, Cracker Barrel, ADMA, CRISPR Trending With Analysts
PremiumWeekend Updates
Nutrien, CAVA, Cracker Barrel, ADMA, CRISPR Trending With Analysts
1M ago
NTR
ADMA
Adma Biologics resumed with an Outperform at Raymond James
PremiumThe Fly
Adma Biologics resumed with an Outperform at Raymond James
1M ago
ADMA
ADMA Biologics Shareholders Back Board, Auditor and Pay
PremiumCompany AnnouncementsADMA Biologics Shareholders Back Board, Auditor and Pay
2M ago
8K
ADMA
ADMA Biologics Earnings Call: ASCENIV Fuels Profits
Premium
Company Announcements
ADMA Biologics Earnings Call: ASCENIV Fuels Profits
2M ago
ADMA
Adma Biologics price target lowered to $20 from $24 at Mizuho
Premium
The Fly
Adma Biologics price target lowered to $20 from $24 at Mizuho
2M ago
ADMA
Adma Biologics price target lowered to $18 from $21 at Canaccord
PremiumThe Fly
Adma Biologics price target lowered to $18 from $21 at Canaccord
2M ago
ADMA
Adma Biologics options imply 12.3% move in share price post-earnings
PremiumThe Fly
Adma Biologics options imply 12.3% move in share price post-earnings
2M ago
ADMA
Adma Biologics reports Q1 EPS 19c, consensus 20c
PremiumThe Fly
Adma Biologics reports Q1 EPS 19c, consensus 20c
2M ago
ADMA
Adma Biologics sees FY26 revenue $530M-$560M, consensus $629.1M
PremiumThe Fly
Adma Biologics sees FY26 revenue $530M-$560M, consensus $629.1M
2M ago
ADMA
Analyst Reaffirms Buy Rating on ADMA Biologics, Citing Expanded Asceniv FDA Label and Strong Growth Outlook Despite Bivigam Concerns
PremiumRatingsAnalyst Reaffirms Buy Rating on ADMA Biologics, Citing Expanded Asceniv FDA Label and Strong Growth Outlook Despite Bivigam Concerns
3M ago
ADMA
Adma Biologics announces FDA approval for Asceniv sBLA
Premium
The Fly
Adma Biologics announces FDA approval for Asceniv sBLA
3M ago
ADMA
ADMA Biologics Gains FDA Approval for Expanded ASCENIV Label
Premium
Company Announcements
ADMA Biologics Gains FDA Approval for Expanded ASCENIV Label
3M ago
8K
ADMA
ADMA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ADMA Earnings this Week: How Will it Perform?
3M ago
ADMA
CrowdStrike, ADMA, Achieve, AbbVie, Valero Trending With Analysts
PremiumWeekend Updates
CrowdStrike, ADMA, Achieve, AbbVie, Valero Trending With Analysts
3M ago
VLO
ABBV
Adma Biologics initiated with a Buy at Canaccord
PremiumThe Fly
Adma Biologics initiated with a Buy at Canaccord
3M ago
ADMA
Adma Biologics initiated with a Buy at Canaccord
PremiumThe Fly
Adma Biologics initiated with a Buy at Canaccord
3M ago
ADMA
Adma Biologics price target lowered to $24 from $30 at Mizuho
PremiumThe FlyAdma Biologics price target lowered to $24 from $30 at Mizuho
3M ago
ADMA
Midday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
Premium
The Fly
Midday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
4M ago
U
CG
Adma Biologics call volume above normal and directionally bullish
Premium
The Fly
Adma Biologics call volume above normal and directionally bullish
4M ago
ADMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >